Cohort 2023↗
Aperture Bio
Combining the study of proteins and their functions to facilitate the development of cancer drugs.
← All companies
Cohort 2023
Serinus Biosciences
Designing rational combination therapies using AI to overcome clinically-relevant disease resistance mechanisms.
Part of the Studio communityCohort 2023
Keep exploring
More from this cohort.
Cohort 2023↗
Ascent Bio
Optimizing the search for candidate molecules with a pretrained, deep learning, API-oriented platform.
Cohort 2023↗
Brainify.AI
Optimizing depression treatment through AI-driven precision psychiatry.
Connect with MDSS
Your next step starts
with a conversation.
Building a company, exploring the program or looking to contribute? Tell us what you have in mind.
Let’s talk Founders · Partners · Mentors